middle.news
How Island Pharmaceuticals Is Fast-Tracking Galidesivir’s FDA Approval
9:09am on Thursday 30th of October, 2025 AEDT
•
Healthcare
Read Story
How Island Pharmaceuticals Is Fast-Tracking Galidesivir’s FDA Approval
9:09am on Thursday 30th of October, 2025 AEDT
Key Points
Acquisition of Galidesivir antiviral program from BioCryst Pharmaceuticals completed
FDA granted Type C meeting under open IND to discuss Animal Rule fast-track approval
Historical non-human primate studies show up to 94% survival in Marburg and 100% in Ebola
Raised over $1.1 million through option exercises from major shareholders
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Island Pharmaceuticals (ASX:ILA)
OPEN ARTICLE